Novartis AG - ADR
NYSE:NVS 4:00:00 PM EDT
| Market Cap (Intraday) | 197.16B |
| Current PE | 28.05 |
| Forward PE | 14.59 |
| 2yr Forward PE | 13.35 |
| 10-Day MA | $98.80 |
| 50-Day MA | $99.05 |
| 200-Day MA | $86.52 |
Novartis AG - ADR Stock, NYSE:NVS
Lichtstrasse 35, Basel, Basel-Stadt (Basle Town) 4056
Switzerland
Phone: +41.61.324.11.11
Number of Employees: 101703
Description
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.